Gene: ATF6
Official Full Name: activating transcription factor 6provided by HGNC
Gene Summary: This gene encodes a transcription factor that activates target genes for the unfolded protein response (UPR) during endoplasmic reticulum (ER) stress. Although it is a transcription factor, this protein is unusual in that it is synthesized as a transmembrane protein that is embedded in the ER. It functions as an ER stress sensor/transducer, and following ER stress-induced proteolysis, it functions as a nuclear transcription factor via a cis-acting ER stress response element (ERSE) that is present in the promoters of genes encoding ER chaperones. This protein has been identified as a survival factor for quiescent but not proliferative squamous carcinoma cells. There have been conflicting reports about the association of polymorphisms in this gene with diabetes in different populations, but another polymorphism has been associated with increased plasma cholesterol levels. This gene is also thought to be a potential therapeutic target for cystic fibrosis. [provided by RefSeq, Aug 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO00189 | ATF6 Knockout cell line (HeLa) | Human | ATF6 | 1:3~1:6 | Negative | Online Inquiry |
KO02843 | ATF6 Knockout cell line (HCT 116) | Human | ATF6 | 1:2~1:4 | Negative | Online Inquiry |
KO02844 | ATF6 Knockout cell line (HEK293) | Human | ATF6 | 1:3~1:6 | Negative | Online Inquiry |
KO02845 | ATF6 Knockout cell line (A549) | Human | ATF6 | 1:3~1:4 | Negative | Online Inquiry |
ATF6 Gene Knockout Cell Lines are genetically engineered cell lines specifically designed to study the functions and pathways associated with the ATF6 (Activating Transcription Factor 6) gene, a key regulator of the unfolded protein response (UPR). The ATF6 gene plays a crucial role in cellular stress responses, particularly in endoplasmic reticulum (ER) stress, by facilitating the adaptive response to the accumulation of misfolded proteins. By eliminating the expression of ATF6, these knockout cell lines offer researchers a powerful tool to dissect the molecular mechanisms underlying the UPR and its implications in various diseases.
The core functionality of the ATF6 Gene Knockout Cell Lines lies in their ability to help elucidate the role of ATF6 in cellular homeostasis and its impact on cell survival under stress conditions. Without ATF6, the UPR signaling cascade is disrupted, allowing for investigation into the contributions of other pathways, such as PERK and IRE1, and their interactions in response to ER stress conditions. This nuanced understanding is vital for researchers seeking to uncover the links between cellular stress responses and diseases such as neurodegeneration, diabetes, and cancer.
From a scientific perspective, these knockout cell lines are invaluable in both fundamental research and clinical applications. They enable researchers to model diseases associated with dysregulated protein homeostasis and can be used for drug discovery, especially in the identification of compounds that restore UPR functionality. Additionally, they serve as a platform for the assessment of therapeutic approaches aimed at mitigating the effects of ER stress-related disorders.
The unique selling point of ATF6 Gene Knockout Cell Lines is their specificity and reproducibility, providing researchers with consistent results that enhance experimental reliability. Compared to conventional methods involving transient or stable knockdown approaches, these knockout models offer a more robust platform to study the long-term consequences of ATF6 deficiency, with potential for easy integration into various experimental setups.
For researchers and clinicians alike, the ATF6 Gene Knockout Cell Lines represent a critical advancement in the field of cell biology and medical research. By facilitating a better understanding of ER stress mechanisms, this product supports the exploration of innovative therapeutic avenues and enhances the potential for translational applications in treating ER stress-related conditions. Our company, with its deep-rooted expertise in developing high-quality genetic tools and models, is committed to empowering scientists with the state-of-the-art resources they need to drive their research forward.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.